普通放疗和适形调强放疗治疗局部晚期宫颈癌的临床研究被引量：25

Clinical observation between conventional radiotherapy and intensity-modulated radiotherapy in the treatment of locally advanced cervical cancer

下载PDF

导出

摘要随机将局部晚期宫颈癌患者分为调强放疗组和普通放疗组,每组各36例。调强放疗与普通放疗在急性放射性肠炎和急性放射性膀胱炎的发生率方面差异有统计学意义(P<0.05)。调强放疗组近期疗效和3年总生存率优于普通放疗组,但差异无统计学意义。调强放疗减少了放疗毒副反应,不降低患者生存率,是治疗局部晚期宫颈癌(IIB-IVA期)的重要手段。 A total of 72 patients with locally advanced cervical cancer were divided into conventional radiotherapy group with 36 patients and IMRT group with 36 patients according to random number table. Acute radiation enteritis and acute radiation bladder difference were statistically significant （ P 〈 0.05 ）. Short-term effect and the 3-year overall survival were higher than the conventional radiotherapy, but the difference was not statistically significant. IMRT group reduced the toxicity of radiotherapy, and improved the survival rate of patients. IMRT is the effective treatment method.

作者崔亚云张红雁程勇赵于飞高劲张洪波

机构地区安徽医科大学附属省立医院肿瘤放疗科

出处《安徽医科大学学报》 CAS 北大核心 2016年第2期302-304,共3页 Acta Universitatis Medicinalis Anhui

基金安徽省自然科学基金(编号:1308085MH122)

关键词宫颈鳞癌普通放疗调强放疗毒副反应生存期 cervical squamous cell carcinoma ordinary radiotherapy IMRT toxicity survival

分类号 R737.9 [医药卫生—肿瘤]

引文网络
相关文献

参考文献10

1Forman D, Bray F, Brewster D H, et al. Cancer incidence in five continents,Vol. X [DB/OL]. Lyon: IARC Science Publication, http:ciS, iarc. fr,2013 -01.
2Bakiu E, Telhaj E, Kozma E, et al. Comaparison of 3D CRT and IMR T trat-ment plans [J]. Acta Inform Med,2013,21 ( 3 ) : 211 - 2.
3Chen C C, Lin J C, Jan J S, et al. Definitive intensity-modulated ra- diation therapy with concurrent chemotherapy for patients with lo- cally advanced cervical cancer [ J]. Gynecol Oncol, 2011,122 (1) : 9 -13.
4Fernandez-Ots A, Crook J. The role of intensity modulated radio- therapy in gynecological radiotherapy: present and future [ J ]. Rep Pract Oncol Radiother,2013, 18(6) :363 -70.
5Nikola C, Coya T, Kamilla K, et al. IMRT with 18FDG-PET/CT based simultaneous integrated boost for treatment of nodal positive cervical cance[ J ]. Radiat Oncol,2014,9 ( 3 ) :83 - 91.
6Ryuji K, Naoto F, Hiroshi K, et al. Posttreatment cut-off levels of squamous cell carcinoma antigen as a prognostic factor in patients with locally advanced cervical cancer treated with radiotherapy [ J ]. J Gynecol Onco1,2013,24 (4) :313 - 20.
7莫玉珍,曾定元,钟华,黄东宁.局部晚期宫颈癌调整调强放射治疗计划的疗效及放射损伤研究[J].中国肿瘤临床与康复,2014,21(3):339-342. 被引量：9
8Hsieh C H,Tsai S J,Chiou W Y,et al. Better survival with three- dimensional conformal radiotherapy than with conventional radio- therapy for cervical cancer: apopulation-based study [ J ]. ISRN Onco1,2013,10:729 - 819.
9肖锋,宋晖,魏丽春,刘隽悦,谭丽娜,石梅.宫颈癌调强放疗膀胱受照剂量的评价[J].中华肿瘤防治杂志,2011,18(6):463-465. 被引量：16
10阮莎莎,伍钢,丁乾,宋颖秋,李贵玲.ⅡB期宫颈癌全盆盒式放疗与调强放疗的剂量学比较及临床观察[J].临床肿瘤学杂志,2014,19(3):235-239. 被引量：7

二级参考文献29

1李爱苓,孙建衡,晁红霞,王桂香.子宫颈癌放射治疗致放射性膀胱炎378例临床分析[J].中华妇产科杂志,1995,30(12):741-743. 被引量：16
2谷铣之,殷蔚伯,余子豪,等.肿瘤放射治疗学[M].北京:中国协和医科大学出版社,2008:573.
3Van de Bunt L, Van der Heide U A, Ketelaars M, et al. Conventional conformal and intensity-modulated radiation therapy treatment planning of external beam radiotherapy for cervical cancer: the impact of tumor regression[J]. Int J Radiat Oncol Biol Phys, 2006, 64(1):189-196.
4D'Souza W D, Ahamad A A, Lyer R B, et al. Feasibility of dose escalation using intensity-modulated radiotherapy in posthysterectomy cervical carcinoma [J]. Int J Radiat Oncol Biol Phys, 2005, 61(4): 1062-1070.
5Baucal M, Babic J, Kuzmanovic Z. Rectal dosimetry in intracavitary applietions of cervix carcinoma: Comparison of two methods [J]. Arch Oncol, 2002,10 (4) :253-259.
6Ahmed R S, Kim R Y, Duan J, et al. IMRT dose escalation for positive para-aortic lymph nodes in patients with locally advanced cervical cancer while reducing dose to bone marrow and other organ s at risk[J]. Int J Radiat Oncol Biol Phys, 2004, 60(2) :505-512.
7Schefter T E, Kavanagh B D, Wu Q W, et al. Technical considerations in the application of intensity-modulated radiotherapy as a concomitant integrated boost for locally-advanced cervix cancer [J]. MedDosim, 2002, 27(2):177-184.
8Cengiz M, Gurdalli S, Selek U, et al. Effect of bladder disten sion on dose distribution of intracavitary brachytnerapy for cervi cal cancer: three-dimensional computed tomography plan evaluation[J]. Int J Radiat Oncol Biol Phys, 2008, 70(2): 464-468.
9Petter R, Haie-Meder C, Van Limbergen E, et al. Recommendations from gynaecological(GYN) GEC ESTRO working group ( Ⅱ ) : Concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology[J].Radiotheand Oncol, 2006, 78(1): 67-77.
10Yang L,Lv Y.Possible risk factors associated with radiationproctitis or radiation cystitis in patients with cervical carcinomaafter radiotherapy[J].Asian Pac J Cancer Prev,2012,13;6251-6255.